Original Source(s)
Related Content
Enterovirus diversity may limit treatment advances
Research highlights expanding diagnostic capabilities but persistent gaps in antiviral therapy and vaccine coverage for pediatric enterovirus infections.
September 8, 2026
-
4 min
Frailty may not limit semaglutide benefits
Patients with greater frailty showed larger improvements in health-related quality of life, while cardiovascular treatment effects did not differ significantly across frailty categories.
October 16, 2026
-
5 min